Carcinoembryonic Antigen Market Dynamics: Analyzing Trends and Insights

12 hours ago

The global carcinoembryonic antigen (CEA) market, a key diagnostic and monitoring tool in oncology, was valued at USD 2.03 billion in 2024. The market is projected to expand from USD 2.13 billion in 2025 to USD 3.16 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 5.06% during the forecast period (2025–2033).

Loading comments...